- Demant’s total revenue for the first half of the year was DKK11.25 billion, which is below the estimated DKK11.41 billion.
- Revenue from hearing aids was DKK6.22 billion, falling short of the DKK6.33 billion estimate.
- Diagnostic revenue was DKK1.19 billion, not meeting the DKK1.23 billion estimate.
- Market analysts’ recommendations include 16 buy ratings, 6 hold ratings, and 1 sell rating for Demant.
“`
William Demant Holding A/S on Smartkarma
Analysts on Smartkarma are closely following William Demant Holding A/S, as shown in the recent coverage by Baptista Research. In their report titled “Demant A/S: Initiation of Coverage- Can AI-Powered Hearing Tech Disrupt the Global Market?“, Baptista Research delves into Demant’s financial results for 2024. The company experienced a mixed performance with both positive and challenging developments shaping its outlook. Despite achieving a 4% growth in revenue, driven by organic growth and acquisitions totaling DKK 22.4 billion, there were concerns highlighted. While gross profit improved by 5%, the company’s EBIT declined by approximately 2% (DKK 100 million) compared to the prior year, indicative of hurdles faced during the fiscal period.
A look at William Demant Holding A/S Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 1 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
William Demant Holding A/S, a company specializing in products for individuals with hearing loss, is positioned for a moderately positive long-term outlook based on its Smartkarma Smart Scores. While the company scored relatively low in terms of dividend yield, its values, growth potential, resilience, and momentum all received moderate scores. This suggests that William Demant Holding A/S has room for improvement in its dividend payouts, but shows promise in areas such as growth, resilience to market fluctuations, and overall momentum.
Demant A/S focuses on developing, manufacturing, and selling a range of products aimed at aiding individuals with hearing impairments in connecting and communicating effectively. The company’s offerings include hearing devices and implants, diagnostic instruments, and personal communication solutions. With a global customer base, William Demant Holding A/S is poised to capitalize on its strengths in growth, resilience, and momentum while potentially enhancing its dividend offerings in the future.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars
